Compile Data Set for Download or QSAR
maximum 50k data
Found 13 with Last Name = 'riccardi' and Initial = 'g'
TargetAdenosine receptor A1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50019514(CHEMBL3290772)
Affinity DataIC50:  8.00E+3nMAssay Description:Inhibition of adenosine A1 receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50019516(CHEMBL3291063)
Affinity DataIC50:  8.00E+3nMAssay Description:Inhibition of adenosine A1 receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50019515(CHEMBL3291062)
Affinity DataIC50:  8.00E+3nMAssay Description:Inhibition of adenosine A1 receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50019519(CHEMBL3291056)
Affinity DataIC50:  8.00E+3nMAssay Description:Inhibition of adenosine A1 receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50019515(CHEMBL3291062)
Affinity DataIC50:  1.60E+4nMAssay Description:Inhibition of human ERG by medium-throughput electrophysiologyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50019511(CHEMBL3290766)
Affinity DataIC50:  2.19E+4nMAssay Description:Inhibition of mu opioid receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50019518(CHEMBL3291066)
Affinity DataIC50: >3.30E+4nMAssay Description:Inhibition of human ERG by medium-throughput electrophysiologyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50019516(CHEMBL3291063)
Affinity DataIC50: >3.30E+4nMAssay Description:Inhibition of human ERG by medium-throughput electrophysiologyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50019514(CHEMBL3290772)
Affinity DataIC50: >3.30E+4nMAssay Description:Inhibition of human ERG by medium-throughput electrophysiologyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50019517(CHEMBL3291065)
Affinity DataIC50: >3.30E+4nMAssay Description:Inhibition of human ERG by medium-throughput electrophysiologyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50019512(CHEMBL3290767)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human ERG by medium-throughput electrophysiologyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50019511(CHEMBL3290766)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human ERG by medium-throughput electrophysiologyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50019513(CHEMBL3290768)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human ERG by medium-throughput electrophysiologyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed